33 results about "Soluble Tablet" patented technology

The invention discloses an imatinib mesylate pellet tablet and a preparation method thereof. The preparation method comprises the following steps: firstly, preparing a main drug, namely imatinib mesylate, into a gastric-soluble coating pellet by a fluidized bed coating process, and then mixing the coating pellet with a filling agent, a disintegrating agent, an adhesive, a plasticizing agent, a lubricating agent and the like to prepare the gastric-soluble tablet by a compressing dry granulation technology. The tablet can be directly swallowed and can be quickly disintegrated into pellets in water so as to be convenient for patients with dysphagia and especially children to take. The accurate dose of the tablet can be ensured, and the tablet can be taken safely and conveniently.

The invention relates to the technical field of medicines and in particular relates to a hydrobromic acid vortioxetine gastric-soluble tablet and a preparation method thereof. The hydrobromic acid vortioxetine gastric-soluble tablet comprises the following components in percentage by weight: 4.24% of hydrobromic acid vortioxetine, 1.0-5.0% of a lubricating agent, 81-91% of a filling agent, 2-5% of a binding agent and 2-15% of a disintegrating agent. Dissolution rate of the hydrobromic acid vortioxetine gastric-soluble tablet is similar to the foreign original standard, so that the hydrobromic acid vortioxetine gastric-soluble tablet has good application prospect and market prospect.

The invention provides a hydrochloric acid boningmycin solid preparation, which is a soluble tablet or a dispersible tablet. The compositions and weight percentages of the hydrochloric acid boningmycin solid preparation are as follows: 0.5 to 50wt% of hydrochloric acid boningmycin, 15 to 99.4wt% of fillers achieving a filling effect, 0 to 20wt% of disintegrants achieving a disintegration effect, 0 to 10 wt% of adhesives achieving an adhesion effect and 0.1 to 5wt% of lubricants achieving a lubrication effect. The invention also provides a preparation method of the soluble tablet and the dispersible tablet. By adopting the hydrochloric acid boningmycin tablet provided by the invention, on the one hand, the deficiency that preparations such as ointment, gel, and the like have poor stabilityafter being placed for a long time under a room temperature condition is overcome, and the storage and the carrying are facilitated; and on the other hand, before being used, the tablet is added to aspecial solvent so as to be dissolved or dispersed to form a water solution or an injectable suspension with certain viscosity, and thereby the tablet also has the advantage of a semi-solid or liquidexternal preparation on the aspects of the use and the pharmaceutical effect.

The invention discloses a soluble tablet containing chlorobromoisocyanuric acid and kasugamycin and a preparation method thereof. The soluble tablet uses chlorobromoisocyanuric acid and kasugamycin as active ingredients, and the soluble tablet has completely water-soluble , No insoluble impurities, rapid dissolution characteristics. The soluble tablet is granulated by dry method and produced by a tablet press machine, with low production energy consumption, no dust drift during production and use, and no pollution to human body and environment. The dissolvable tablet conforms to the national requirements for the development of pesticide products in the direction of green environmental protection, can better utilize the advantages of chlorobromoisocyanuric acid and kasugamycin products, and prolong the product life cycle.

The invention relates to a compound nateglinide valsatan medicinal composition, which is a dual-layer tablet and comprises a first layer of nateglinide and a second layer of valsatan, wherein the first layer is delivered from a self-soluble tablet to be immediately released; and the second layer is released from a self-disintegration or corroded tablet matrix.

The invention relates to a vitamin C soluble tablet. The medicinal composition is vitamin C or calcium salt dihydrate thereof. The invention also provides a preparation method of the vitamin C soluble tablet. A reasonable auxiliary material formula is selected, so that the vitamin C soluble tablet can be quickly disintegrated within 2 minutes in water and becomes a settled solution form, so that the drug is quickly obtained. By adopting the preparation method disclosed by the invention, vitamin C can be well protected, and oxidation is reduced. Meanwhile, the preparation time is also shortened when the tablet with excellent performance is obtained, and the cost is reduced. The preparation method disclosed by the invention is simple and convenient in process, easy to carry out, and applicable to massive industrial production.

The invention discloses an imatinib mesylate pellet tablet and a preparation method thereof. The preparation method comprises the following steps: firstly, preparing a main drug, namely imatinib mesylate, into a gastric-soluble coating pellet by a fluidized bed coating process, and then mixing the coating pellet with a filling agent, a disintegrating agent, an adhesive, a plasticizing agent, a lubricating agent and the like to prepare the gastric-soluble tablet by a compressing dry granulation technology. The tablet can be directly swallowed and can be quickly disintegrated into pellets in water so as to be convenient for patients with dysphagia and especially children to take. The accurate dose of the tablet can be ensured, and the tablet can be taken safely and conveniently.

The invention relates to a thymosin enteric-coated tablet and a preparation method thereof. The thymosin enteric-coated tablet comprises thymosin, elinic acid, a pharmaceutically acceptable carrier, an enteric coating and an optional absorption promoter. The addition of Potentinic acid in the thymosin enteric-coated tablet of the present invention can not only effectively solve the release fluctuation of thymosin in the intestinal tract due to pH changes, but also has a considerable promotion effect on the activity of thymosin, further enhancing the strength of the thymosin enteric-coated tablet. immunomodulatory effect.

The invention provides a hydrochloric acid boningmycin solid preparation, which is a soluble tablet or a dispersible tablet. The compositions and weight percentages of the hydrochloric acid boningmycin solid preparation are as follows: 0.5 to 50wt% of hydrochloric acid boningmycin, 15 to 99.4wt% of fillers achieving a filling effect, 0 to 20wt% of disintegrants achieving a disintegration effect, 0 to 10 wt% of adhesives achieving an adhesion effect and 0.1 to 5wt% of lubricants achieving a lubrication effect. The invention also provides a preparation method of the soluble tablet and the dispersible tablet. By adopting the hydrochloric acid boningmycin tablet provided by the invention, on the one hand, the deficiency that preparations such as ointment, gel, and the like have poor stabilityafter being placed for a long time under a room temperature condition is overcome, and the storage and the carrying are facilitated; and on the other hand, before being used, the tablet is added to aspecial solvent so as to be dissolved or dispersed to form a water solution or an injectable suspension with certain viscosity, and thereby the tablet also has the advantage of a semi-solid or liquidexternal preparation on the aspects of the use and the pharmaceutical effect.

The invention relates to a pitavastatin soluble tablet composition and preparation process wherein the composition is prepared from soluble medicinal auxiliary materials by a predetermined proportion, the composition becomes solution state in oral liquid, thus facilitating the dissolution, absorption and application of pitavastatin calcium.

The invention relates to an amantadine hydrochloride soluble tablet exclusively used for children, which is made up of an effective dose of hydrochloric acid admantadine and a water soluble medical excipient that can rapidly disintegrate and release drugs. Patients determine the dose of the tablet according to weight, thus realizing personalized medicine administration and ensuring the medicine intake dose more appropriate with higher security. Once in solution, the medicine instantly becomes a sweet and sour beverage, which is more easily to be accepted by children; meanwhile the medicine solution is easily to be absorbed fully and the bioavailability is high.